Skip to main content
See every side of every news story
Published loading...Updated

Annovis Bio to Present Buntanetap Clinical Data at AD/PD 2026 Conference

Summary by MyChesCo
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced it will present two research updates on its investigational drug buntanetap at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases, scheduled for March 17 through March 21 in Copenhagen, Denmark. The company said the presentations will include clinical data from studies of buntanetap in Parkinson’s disease and an update on its ongoing Phase 3 trial in early-stage Alzhei…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MyChesCo broke the news in on Tuesday, March 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal